Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AVIR
Stock Latest News
Company Announcements
Atea’s Renal and Hepatic Impairment Study Marks a Key De-Risking Step for AVIR Investors
4d ago
AVIR
Premium
Ratings
Hold Rating Maintained on Competitive HCV Data but Commercial Uncertainty; Price Target Reiterated at $6
6d ago
AVIR
Premium
The Fly
Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints
8d ago
AVIR
Premium
Company Announcements
Atea Advances Antiviral Pipeline With New Drug Interaction Study in Opioid Therapy
19d ago
AVIR
Premium
The Fly
Atea Pharmaceuticals initiates AT-587 clinical trial
22d ago
AVIR
Premium
The Fly
Atea Pharmaceuticals completes patient enrollment in C-FORWARD trial
1M ago
AVIR
Premium
Company Announcements
Atea Shareholders Back Directors, Auditors and Executive Pay
1M ago
8K
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Sets Up Catalyst-Rich 2026 Earnings Call
3M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals price target raised to $10 from $6 at Evercore ISI
5M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals’ Earnings Call Flags Pivotal 2026
5M ago
AVIR
Premium
Pre-Earnings
Is AVIR a Buy, Before Earnings?
5M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals presents preclinical results of AT-587
5M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals to highlight strategic priorities for FY26
7M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals completes patient enrollment in C-BEYOND Phase 3 trial
8M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals’ Earnings Call Highlights Progress and Optimism
9M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Advances Antiviral Programs with New Data
9M ago
AVIR
Premium
Pre-Earnings
AVIR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals announces presentation of data on BEM, RZR
9M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals’ New HCV Study: Potential Game-Changer?
9M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals Advances with Key Phase 1 Study on Bemnifosbuvir/Ruzasvir
9M ago
AVIR
Premium
Company Announcements
Atea Pharmaceuticals’ Promising HCV Treatment Study: Key Insights for Investors
9M ago
AVIR
Premium
The Fly
Atea Pharmaceuticals to present data on bemnifosbuvir, ruzasvir combination
10M ago
AVIR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
